| Devatis AG - Temozolomid Devatis 250 mg, Kapseln | | 68606 | | 06 | | Temozolomid Devatis 250 mg | | Kapseln | | L01AX03 | | Temozolomide | | 17.11.2022 | | |
| | Composition | | temozolomidum 250 mg, lactosum 154.3 mg, carboxymethylamylum natricum A corresp. natrium max. 0.9 mg, silica colloidalis anhydrica, acidum tartaricum, acidum stearicum, Kapselhülle: gelatina, E 171, Drucktinte: lacca, E 172 (nigrum), propylenglycolum, ammonii hydroxidum, pro capsula. | | Packungsbestandteile | | Capsules | | | | | Active Agent | Dose |
|---|
| Temozolomide | 250 mg |
| | BAG: Active Agent | Dose |
|---|
| Temozolomide | 250 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| | | | | | | | | Tartaric Acid | | | | | | | | | | | | | | color. | | | | color. | | Gelatina | | Kapselhülle | | | | Drucktinte | | | 154.3 mg | | | | | | | Propylenglycol | | | | Silica Colloidalis Anhydrica | | |
| |
| |
|
